scispace - formally typeset
D

Dominique Figarella-Branger

Researcher at Aix-Marseille University

Publications -  583
Citations -  39329

Dominique Figarella-Branger is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Medicine & Glioma. The author has an hindex of 80, co-authored 543 publications receiving 30147 citations. Previous affiliations of Dominique Figarella-Branger include Centre national de la recherche scientifique & University of the Mediterranean.

Papers
More filters
Journal Article

Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment.

TL;DR: The case shows that for any subject presenting myalgia with rhabdomyolysis triggered by fluoroquinolone treatment, the presence of a latent myopathy should be investigated.
Journal ArticleDOI

Expression of peptide-23/pancreatitis-associated protein and Reg genes in human pituitary and adenomas: comparison with other fetal and adult human tissues.

TL;DR: The results show that all of the human fetal and adult tissues examined express at least one of the different transcripts of the PAP/Reg family, suggesting that the regulation of these homologous genes is coordinately controlled.
Journal ArticleDOI

Sarcomes aortiques avec embolies périphériques: à propos de deux cas

TL;DR: In this paper, the authors report two cases of aortic angiosarcomas, which were similar and characterized by a typical pejorative clinical course, with peripheric emboli and many osteolytic metastasis.
Journal ArticleDOI

Investigation of fluoroquinolone‐induced myalgia using 31P magnetic resonance spectroscopy and in vitro contracture tests

TL;DR: The adverse effects recorded in the 3 patients are related to a preexisting muscular anomaly revealed by FQ treatment, and a significant reduction of pH changes measured at the end of exercise and a faster rate of proton efflux measured during recovery in all patients.
Journal ArticleDOI

Tubular CD146 expression in nephropathies is related to chronic renal failure.

TL;DR: Renal CD146 expression is of interest for determining the pathogenesis of mesangial alterations during glomerular injuries and of tubular phenotypic changes during chronic renal failure.